FDA Clears New Blood Clot Removal System for PE
The FDA cleared the Hēlo Thrombectomy System to remove blood clots from the lungs in patients with chronic venous thromboembolism.
The FDA cleared the Hēlo Thrombectomy System to remove blood clots from the lungs in patients with chronic venous thromboembolism.
The Inspire hypoglossal nerve stimulation device provides an alternative for eligible adolescents with Down syndrome who cannot tolerate CPAP.
The American Lung Association’s 2023 "State of Lung Cancer" report reveals improvement in five-year survival rate across the US, including for people of color.
Patient-reported mucus color reflects underlying inflammation and flare-up severity in adults with bronchiectasis.
A $20.7M federal grant will fund a 5-year inhaled vaccines initiative at the Icahn School of Medicine at Mount Sinai beginning with development of an avian influenza nasal spray prototype.
Ai identified intubated patients who pass standard extubation readiness tests but remain at twice the risk of returning to a ventilator.
Only about 18% of eligible US adults underwent lung cancer screening in 2022, lagging far behind rates for breast and colorectal cancer screenings.
Resmed announced the US introduction of its AirTouch F40, a fabric, full face CPAP mask option. It will be commercially available starting October 28, 2026.